Annual SGA
$112.62 M
+$25.04 M+28.58%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual SGA is $112.62 million, with the most recent change of +$25.04 million (+28.58%) on December 31, 2023.
- During the last 3 years, CERE annual SGA has risen by +$66.81 million (+145.83%).
Performance
CERE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$36.23 M
-$6.21 M-14.62%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly SGA is $36.23 million, with the most recent change of -$6.21 million (-14.62%) on March 31, 2024.
- Over the past year, CERE quarterly SGA has increased by +$10.18 million (+39.06%).
Performance
CERE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$5.37 B
-$460.47 M-9.37%
March 31, 2024
Summary
- As of February 10, 2025, CERE TTM SGA is -$5.37 billion, with the most recent change of -$460.47 million (-9.37%) on March 31, 2024.
- Over the past year, CERE TTM SGA has dropped by -$5.47 billion (-5689.37%).
Performance
CERE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CERE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.6% | +39.1% | -5689.4% |
| 3 y3 years | +145.8% | +107.0% | -8802.0% |
| 5 y5 years | +239.6% | +107.0% | -8802.0% |
CERE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -48.3% | -14.6% | -54.0% | +154.6% | at low |
| 5 y | 5-year | at high | -70.5% | -14.6% | -71.5% | >+9999.0% | at low |
| alltime | all time | at high | -70.5% | -14.6% | -71.5% | >+9999.0% | at low |
Cerevel Therapeutics Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $36.23 M(-14.6%) | $127.48 M(+13.2%) |
| Dec 2023 | $112.62 M(+28.6%) | $42.44 M(+62.9%) | $112.62 M(+17.2%) |
| Sep 2023 | - | $26.05 M(+14.5%) | $96.12 M(+2.5%) |
| Jun 2023 | - | $22.76 M(+6.5%) | $93.75 M(+2.5%) |
| Mar 2023 | - | $21.37 M(-17.6%) | $91.45 M(+4.4%) |
| Dec 2022 | $87.59 M(+50.4%) | $25.93 M(+9.5%) | $87.59 M(+11.9%) |
| Sep 2022 | - | $23.68 M(+15.7%) | $78.30 M(+13.5%) |
| Jun 2022 | - | $20.47 M(+16.9%) | $68.99 M(+11.7%) |
| Mar 2022 | - | $17.51 M(+5.2%) | $61.74 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $58.24 M(+27.1%) | $16.65 M(+15.9%) | $58.24 M(+9.2%) |
| Sep 2021 | - | $14.37 M(+8.7%) | $53.35 M(+8.2%) |
| Jun 2021 | - | $13.22 M(-5.7%) | $49.32 M(+0.5%) |
| Mar 2021 | - | $14.01 M(+19.1%) | $49.08 M(+7.1%) |
| Dec 2020 | $45.81 M(+38.1%) | $11.76 M(+13.8%) | $45.81 M(+34.5%) |
| Sep 2020 | - | $10.34 M(-20.3%) | $34.05 M(+43.6%) |
| Jun 2020 | - | $12.97 M(+20.8%) | $23.72 M(+120.8%) |
| Mar 2020 | - | $10.74 M | $10.74 M |
| Dec 2019 | $33.17 M | - | - |
FAQ
- What is Cerevel Therapeutics Holdings annual SGA?
- What is the all time high annual SGA for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual SGA year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly SGA?
- What is the all time high quarterly SGA for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly SGA year-on-year change?
- What is Cerevel Therapeutics Holdings TTM SGA?
- What is the all time high TTM SGA for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings TTM SGA year-on-year change?
What is Cerevel Therapeutics Holdings annual SGA?
The current annual SGA of CERE is $112.62 M
What is the all time high annual SGA for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual SGA is $112.62 M
What is Cerevel Therapeutics Holdings annual SGA year-on-year change?
Over the past year, CERE annual SGA has changed by +$25.04 M (+28.58%)
What is Cerevel Therapeutics Holdings quarterly SGA?
The current quarterly SGA of CERE is $36.23 M
What is the all time high quarterly SGA for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly SGA is $42.44 M
What is Cerevel Therapeutics Holdings quarterly SGA year-on-year change?
Over the past year, CERE quarterly SGA has changed by +$10.18 M (+39.06%)
What is Cerevel Therapeutics Holdings TTM SGA?
The current TTM SGA of CERE is -$5.37 B
What is the all time high TTM SGA for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high TTM SGA is -$3.12 M
What is Cerevel Therapeutics Holdings TTM SGA year-on-year change?
Over the past year, CERE TTM SGA has changed by -$5.47 B (-5689.37%)